We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-9.94%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.23B
AUM Growth
-$302M
Cap. Flow
+$232M
Cap. Flow %
7.17%
Top 10 Hldgs %
15.77%
Holding
277
New
41
Increased
95
Reduced
109
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 33.24%
2 Healthcare 17.69%
3 Industrials 11.31%
4 Consumer Discretionary 8.04%
5 Financials 5.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBTM
26
JBT Marel
JBTM
$6.39B
$29.8M 0.92%
779,348
+107,340
+16% +$3.89M
VRTU
27
DELISTED
Virtusa Corporation
VRTU
$29.4M 0.91%
572,455
-134,537
-19% -$6.83M
ZLTQ
28
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$29.3M 0.91%
916,092
+115,640
+14% +$3.83M
CROX icon
29
Crocs
CROX
$6.55B
$29M 0.9%
2,245,728
-626,442
-22% -$9.08M
STAG icon
30
STAG Industrial
STAG
$7.19B
$28.7M 0.89%
1,573,996
+97,400
+7% +$1.84M
CTCT
31
DELISTED
CONSTANT CONTACT, INC COM
CTCT
$28.6M 0.89%
1,180,435
-251,168
-18% -$6.57M
GIMO
32
DELISTED
Gigamon Inc.
GIMO
$27.2M 0.84%
1,361,612
-131,800
-9% -$3.46M
WNS
33
DELISTED
WNS Holdings
WNS
$27.1M 0.84%
970,145
-111,400
-10% -$3.26M
QGENF
34
DELISTED
QIAGEN NV
QGENF
$27.1M 0.84%
1,051,000
KAMN
35
DELISTED
Kaman Corp
KAMN
$26.4M 0.82%
737,427
+5,399
+0.7% +$211K
IMPV
36
DELISTED
Imperva, Inc.
IMPV
$26.2M 0.81%
400,380
-25,600
-6% -$1.7M
TNC icon
37
Tennant Co
TNC
$1.26B
$25.8M 0.8%
458,470
+2,159
+0.5% +$128K
NKTR icon
38
Nektar Therapeutics
NKTR
$2.58B
$25.4M 0.79%
154,645
+7,127
+5% +$1.26M
BRKR icon
39
Bruker
BRKR
$8.14B
$25.1M 0.78%
1,527,850
-574,450
-27% -$11.2M
LPSN icon
40
LivePerson
LPSN
$32.3M
$24.9M 0.77%
219,464
-778
-0.4% -$105K
KMT icon
41
Kennametal
KMT
$2.52B
$24.4M 0.75%
978,663
-13,600
-1% -$406K
CDNS icon
42
Cadence Design Systems
CDNS
$93.4B
$23.9M 0.74%
1,155,100
-105,100
-8% -$2.14M
MLNX
43
DELISTED
Mellanox Technologies, Ltd.
MLNX
$23.6M 0.73%
624,093
-51,300
-8% -$2.2M
FIVE icon
44
Five Below
FIVE
$13.5B
$23.5M 0.73%
700,573
-206,799
-23% -$7.51M
CNMD icon
45
CONMED
CNMD
$1.47B
$23.5M 0.73%
492,134
+26,700
+6% +$1.47M
CYNO
46
DELISTED
Cynosure, Inc. Class A
CYNO
$22.8M 0.71%
760,541
+254,413
+50% +$9.14M
TER icon
47
Teradyne
TER
$59.3B
$22.2M 0.69%
1,234,878
-105,500
-8% -$1.94M
QLIK
48
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$21.7M 0.67%
595,500
-37,600
-6% -$1.45M
SLAB icon
49
Silicon Laboratories
SLAB
$7.23B
$20.5M 0.63%
492,580
-58,900
-11% -$2.69M
ISIL
50
DELISTED
Intersil Corp
ISIL
$20.1M 0.62%
1,714,395
-213,200
-11% -$2.38M

Similar funds

Granahan Investment Management's Q3 2015 Portfolio in Review

As of Q3 2015, Granahan Investment Management held 277 positions worth $3.23B, down 8.6% from $3.53B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Granahan Investment Management deployed $232M of net new capital in Q3 2015, opening 41 new positions and adding to 95 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 250,380 shares worth $33.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Bruker, an estimated $11.2M trimmed.

  • Granahan Investment Management's largest Q3 2015 buy was iShares Russell 2000 Growth ETF: 250,380 shares worth $33.5M.
  • Granahan Investment Management added most to DEMANDWARE INC COM STK (DE) in Q3 2015, an estimated $15.5M increase.
  • Granahan Investment Management's biggest Q3 2015 reduction was Bruker, cutting an estimated $11.2M.
  • Granahan Investment Management fully exited Vertex Pharmaceuticals in Q3 2015, selling an estimated $24M.
  • Granahan Investment Management's ten largest holdings make up 16% of its $3.23B portfolio in Q3 2015.
  • Granahan Investment Management opened 41 new positions and closed 22 in Q3 2015.
  • Granahan Investment Management's portfolio value fell 8.6% quarter-over-quarter to $3.23B.

Based on Granahan Investment Management's 13F filing for Q3 2015, filed 12 Nov 2015.